What is Zim Laboratories Ltd (ZIMLAB) share price return in the past 10 years?

Data is not available for this company

What is the share price of Zim Laboratories Ltd (ZIMLAB)?

Company share prices are keep on changing according to the market conditions. The current trading price of Zim Laboratories Ltd (ZIMLAB) on 04-Jun-2026 16:59:59 at 16:59 is 108.80.

What is the P/E ratio of Zim Laboratories?

The latest standalone P/E ratio of Zim Laboratories as of 04-Jun-2026 is 97.66.

What is the P/B ratio of Zim Laboratories Ltd (ZIMLAB)?

The latest standalone P/B ratio of Zim Laboratories Ltd (ZIMLAB) as of 04-Jun-2026 is 2.03.

What is the 52-week high and low of Zim Laboratories Ltd (ZIMLAB)?

The 52-week high of Zim Laboratories Ltd (ZIMLAB) is Rs. 126.95 and the 52-week low is Rs. 59.72.

Zim Laboratories Ltd (ZIMLAB) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Zim Laboratories Ltd (ZIMLAB)
Brand: Zim Laboratories

Zim Laboratories Ltd (ZIMLAB)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 541400 NSE: ZIMLAB Pharmaceuticals & Drugs | Small Cap | Zim Laboratories Share Price

Zim Laboratories Ltd (ZIMLAB)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 541400 NSE: ZIMLAB Pharmaceuticals & Drugs | Small Cap | Zim Laboratories Share Price

Key Metrics

Valuation Multiples

Market Cap

₹583 Cr.

Current Price

₹108.8

52-Week Low / High

₹60 / 127

TTM EPS

₹1.1

TTM Sales

₹370 Cr.

Book Value per Share

₹53.5

P/E Ratio

97.66

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

2.03

In line with its 5-year historical median

Price to Sales (P/S)

1.57

Higher than its 5-year historical median

EV/EBITDA

16.32

Higher than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

4.94%

Underperforms industry median

Return on Capital Employed (ROCE)

8.35%

Underperforms industry median

Return on Assets (ROA)

2.59%

Operating Profit Margin

11.5%

Net Profit Margin

3.13%

Gross Profit Margin

10%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

2.78%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

7.91%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-29.95%

Asset Quality

Promoter Holding

30.35%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹233 Cr.

Equity

₹53.6 Cr.

Face Value

₹10

All Time Low / High

₹14.00 / 151.75

Zim Laboratories stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Zim Laboratories Ltd a good quality company?

Zim Laboratories Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Zim Laboratories Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Zim Laboratories Ltd vs industry peers?

Zim Laboratories Ltd revenue CAGR is 6.49%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Zim Laboratories Ltd?

Promoters hold 30.35% of the Zim Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Zim Laboratories Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of 26.97% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	10%	14.2%	16.1%	15%	4.8%	8.1%	12%	17.5%	10.1%	8.4%	-
Value Creation Index ⓘ	-0.3	0.0	0.2	0.1	-0.7	-0.4	-0.1	0.3	-0.3	-0.4	-
Growth Parameters ⓘ
Sales ⓘ	268	235	272	332	274	304	329	397	365	376	370
Sales YoY Gr.	-	-12.4%	15.7%	22%	-17.3%	10.7%	8.5%	20.4%	-7.8%	2.8%	-
Adj EPS ⓘ	1.7	3.7	2.7	3.2	0.1	1.7	2.1	4.3	2.9	1.8	1.1
YoY Gr.	-	118.5%	-27.5%	19.2%	-98.1%	2700%	25%	106.2%	-33%	-37.6%	-
BVPS (₹) ⓘ	20.5	24.5	28	31	31.2	32.2	34.9	39.9	47.6	49.9	53.5
Adj Net Profit ⓘ	8.1	17.7	12.9	15.3	0.3	8.2	10.2	21.1	14.1	8.8	6
Cash Flow from Ops. ⓘ	22.1	32.1	36.7	37.1	21.3	31.9	47	35.2	11.5	50.6	-
Debt/CF from Ops. ⓘ	4.4	2.5	2.2	2.1	4.2	2.5	1.1	1.7	9.3	2.2	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	3.8%	6.5%	4.5%	2.8%
Adj EPS ⓘ	0.8%	97.7%	-4.8%	-37.6%
BVPSⓘ	10.4%	9.9%	12.7%	4.8%
Share Price	-	29.9%	-0.8%	6.4%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	8.3	16.3	10.1	10.7	0.2	5.3	6.3	11.6	6.6	3.7	2.2
Op. Profit Mgn % ⓘ	11.1	13.5	12.5	12.9	7.2	12.1	11.5	12.9	11	11.5	8
Net Profit Mgn % ⓘ	3	7.5	4.7	4.6	0.1	2.7	3.1	5.3	3.9	2.3	1.6
Debt to Equity ⓘ	1	0.7	0.6	0.5	0.6	0.5	0.3	0.3	0.5	0.5	0.1
Working Cap Days ⓘ	212	233	226	215	258	225	222	188	215	221	108
Cash Conv. Cycle ⓘ	80	104	89	68	79	52	60	58	95	98	26

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	268	235	272	332	274	304	329	397	365	376
Operating Expenses ⓘ +	239	203	238	289	255	267	292	345	325	332
Manufacturing Costs	14	13	14	21	34	30	38	45	53	56
Material Costs	157	120	141	160	143	159	160	199	171	168
Employee Cost	31	33	41	48	35	34	39	46	51	56
Other Costs ⓘ	37	37	43	61	42	43	54	55	50	52
Operating Profit ⓘ	29	32	34	42	20	37	38	51	40	43
Operating Profit Margin (%)	10.9%	13.4%	12.5%	12.8%	7.2%	12.1%	11.5%	12.9%	11.0%	11.5%
Other Income ⓘ +	4	6	3	2	5	2	5	6	5	6
Exceptional Items ⓘ	-5	0	6	0	0	-5	0	0	0	0
Interest ⓘ	14	10	9	11	13	11	8	6	7	11
Depreciation ⓘ	9	9	10	11	13	15	15	16	15	20
Profit Before Tax ⓘ	5	18	24	23	-1	9	19	36	23	18
Tax ⓘ	0	-1	6	7	-3	3	6	11	6	6
Profit After Tax	5	19	18	16	2	6	13	25	17	12
PAT Margin (%)	1.9%	7.9%	6.7%	4.8%	0.6%	1.9%	4.0%	6.3%	4.6%	3.1%
Adjusted EPS (₹)	1.1	3.9	3.8	3.3	0.4	1.2	2.7	5.1	3.4	2.4
Dividend Payout Ratio (%)	15.50%	2.20%	2.20%	5%	0%	0%	0%	0%	0%	0%

Valuation of Zim Laboratories - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	98	118	135	150	151	157	170	194	232	243
Share Capital ⓘ	8	8	8	16	16	16	16	49	49	49
Reserves ⓘ	90	110	127	134	135	141	154	145	183	194
Debt +	91	74	70	62	77	66	36	48	91	93
Long Term Debt	35	28	20	22	27	22	19	25	36	40
Short Term Debt	56	47	50	40	50	45	17	23	55	52
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	47	45	66	72	66	65	82	59	63	72
Others Liabilities ⓘ	21	13	22	40	23	29	49	40	57	57
Total Liabilities ⓘ	257	250	294	324	318	318	337	341	443	464
Fixed Assets
Net Fixed Assets ⓘ +	92	89	94	101	111	103	103	107	160	164
Gross Block	120	98	113	130	153	160	174	192	260	268
Accumulated Depreciation	28	9	19	29	42	56	71	85	100	104
CWIP ⓘ	3	4	8	13	10	10	11	26	40	66
Investments ⓘ	0	0	0	5	8	8	8	8	8	13
Inventories	38	35	52	55	56	54	75	54	81	86
Trade Receivables	89	88	88	90	63	64	81	88	100	94
Cash Equivalents	6	6	4	3	3	8	2	2	1	1
Others Assets ⓘ	30	28	48	57	66	70	56	55	51	41
Total Assets ⓘ	257	250	294	324	318	318	337	341	443	464

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	22	32	37	37	21	32	47	35	11	51
PBT ⓘ	5	18	24	23	-1	14	19	36	23	18
Adjustment ⓘ	29	21	13	24	25	25	21	21	21	31
Changes in Working Capital ⓘ	-11	-4	4	-8	3	-5	7	-15	-30	0
Tax Paid ⓘ	-1	-2	-4	-1	-5	-1	-0	-7	-3	1
Cash Flow From Investing Activity ⓘ +	-12	-7	-26	-23	-19	-6	-14	-35	-72	-41
Capex	-13	-9	-28	-18	-15	-6	-15	-36	-73	-37
Net Investments	1	1	2	-1	-1	0	0	0	1	-0
Others ⓘ	0	0	0	-4	-3	0	0	0	-0	-4
Cash Flow From Financing Activity ⓘ +	-10	-25	-10	-15	-2	-26	-33	1	60	-9
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-4	-5	-3	5	4	-4	-3	3	15	9
Interest Paid ⓘ	-12	-10	-9	-10	-14	-10	-8	-6	-8	-12
Dividend Paid ⓘ	0	-1	-1	-1	-1	-0	-0	-0	-0	-0
Others ⓘ	5	-10	3	-9	9	-11	-22	3	52	-6
Net Cash Flow ⓘ	-0	-0	1	-1	0	0	-0	1	-1	0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	5.34	17.27	14.45	11.22	1.16	3.64	7.96	13.73	7.86	4.94
ROCE (%)	9.97	14.24	16.08	14.96	4.75	8.12	12.02	17.48	10.13	8.35
Asset Turnover Ratio	1.06	0.95	1.01	1.07	0.86	0.96	1.01	1.17	0.93	0.83
PAT to CFO Conversion(x)	4.4	1.68	2.06	2.31	10.5	5.33	3.62	1.4	0.65	4.25
Working Capital Days
Receivable Days	112.10	133.80	117.90	98.30	102.30	76.50	80.20	77.90	94.10	94.10
Inventory Days	55.30	55.40	58.10	58.70	74.10	66.60	71.80	59.40	67.40	81.50
Payable Days	128.70	140	144.20	158.10	175.80	150.70	167.30	129.60	129.80	146.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zim Laboratories Ltd FAQs

The current trading price of Zim Laboratories on 04-Jun-2026 16:59 is ₹108.8.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Zim Laboratories stood at ₹582.6 Cr

The latest P/E ratio of Zim Laboratories as of 03-Jun-2026 is 97.66.

The latest P/B ratio of Zim Laboratories as of 03-Jun-2026 is 2.03.

The 52-week high of Zim Laboratories is ₹127.0 and the 52-week low is ₹59.72.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zim Laboratories is ₹370 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Zim Laboratories Ltd is a average quality company.

The key valuation ratios of Zim Laboratories Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Zim Laboratories Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Zim Laboratories Ltd

ZIM Laboratories Limited is a public limited company domiciled in India engaged in the manufacturing of formulation on drugs. The company also has wholly owned subsidiaries (Zim Laboratories FZE,UAE , SIA Zim Laboratories Limited, Latvia and Zim Health Technologies Limited, India) (the Company and its subsidiaries are together referred to as 'the Group') which are engaged in manufacturing & wholesale of pharmaceutical products, market research and research & development activities.

Business area of the company

The company is engaged in the manufacturing of formulation on drugs and pre formulation on ingredients in India and marketing and selling these within and outside India.

Zim Laboratories Ltd (ZIMLAB)

Zim Laboratories Ltd (ZIMLAB)

Zim Laboratories stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Zim Laboratories - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zim Laboratories Ltd FAQs

About Zim Laboratories Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Zim Laboratories Ltd (ZIMLAB)

Zim Laboratories Ltd (ZIMLAB)

Zim Laboratories stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Zim Laboratories - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zim Laboratories Ltd FAQs

What is the share price of Zim Laboratories?

What is the market cap of Zim Laboratories?

What is the P/E ratio of Zim Laboratories?

What is the P/B ratio of Zim Laboratories?

What is the 52-week high and low of Zim Laboratories?

What is the TTM revenue of Zim Laboratories?

Is Zim Laboratories Ltd a good quality company?

Is Zim Laboratories Ltd undervalued or overvalued?

Is Zim Laboratories Ltd a good buy now?

About Zim Laboratories Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.